Stada Takes ViruProtect Cold Spray To Vietnam, Launches Austria’s First OTC Triptan
Stada Arzneimittel is expanding its presence in Vietnam's $2.4bn OTC market and launching Austria's first non-prescription triptan.
You may also be interested in...
The latest European consumer health industry appointments: GSK names Southern Europe head and adds media chief; Enzymatica's new CEO makes early start; and France's ANSES hires risk assessment director.
Sanofi is pressing ahead with plans to divest up to 150 consumer health brands by selling a portfolio of 16 products marketed in key European countries to Germany's Stada.
The latest global health and wellness industry appointments: Stada hires Uriach's Roura to lead Spanish OTC business; CHPA elects J&J's Goodridge; Valbiotis brings in Ipsen's Bessy; and Mannatech's Bala joins DSA's board.